The 2-5A system in control and interferon-treated K/BALB cells infected with encephalomyocarditis virus.
Meurs
E
E
Krause
D
D
Robert
N
N
Silverman
R H
RH
Hovanessian
A G
AG
D015088:2',5'-Oligoadenylate Synthetase / Q000378:metabolism; D000227:Adenine Nucleotides / Q000378:metabolism*; D000818:Animals; D002478:Cells, Cultured; D004686:Encephalomyocarditis virus / Q000187:drug effects / Q000378:metabolism; D004722:Endoribonucleases / Q000378:metabolism; D004769:Enterovirus Infections / Q000378:metabolism* / Q000382:microbiology / Q000628:therapy; D007372:Interferons / Q000494:pharmacology*; D051379:Mice; D009843:Oligoribonucleotides / Q000378:metabolism*; D014764:Viral Proteins / Q000096:biosynthesis; D014779:Virus Replication / Q000187:drug effects
D000227:Adenine Nucleotides; D009843:Oligoribonucleotides; D014764:Viral Proteins; C023505:2',5'-oligoadenylate; D007372:Interferons; D015088:2',5'-Oligoadenylate Synthetase; D004722:Endoribonucleases; C031956:2-5A-dependent ribonuclease